Femke de Snoo, MD PhD, President and co-founder of Medex15
Femke earned her medical degree followed by a PhD in Clinical Genetics. She gained extensive experience in performing translational research in an international setting at the University of Pennsylvania, at the genetics research department at the LUMC and at the National Human Genome Research Institute at NIH in Bethesda. Femke has extensive experience with cancer patients in the oncogenetic setting and has been involved in multiple clinical research projects. At Agendia -a molecular diagnostics company known for the MammaPrint test- she was as the senior Director Medical Affairs, the liaison between physicians, scientists, and the marketing and sales department.
Lisette Stork-Sloots, MSc, President and co-founder of Medex15
Lisette has 20 years global clinical research experience in Phase 1-4 drug and molecular diagnostic studies. She worked several years at the headquarters of Eli Lilly leading the European oncology clinical development team and as a global program manager for assigned drug development programs (preclinical, phase 1 and 2). At Agendia –a molecular diagnostics company known for the MammaPrint test- she implemented the clinical affairs department and designed, implemented and managed global clinical trials.